Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda M McCall

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JAMA|January 18, 2018
Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-ReplyKarla V Ballman, Linda M McCall, Armando E Giuliano
Journal of Biopharmaceutical Statistics|November 11, 2005
Sample size computation for two-sample noninferiority log-rank testSin-Ho Jung, Sun J Kang, Linda M McCall, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2019
Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical TrialBruce G Haffty, Linda M McCall, Karla V Ballman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancerKatherine E Posther, Linda M McCall, David H Harpole, et al.
American Journal of Surgery|September 17, 2005
Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancerA Marilyn Leitch, Peter D Beitsch, Linda M McCall, et al.
Annals of Surgery|June 29, 2017
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance)Judy C Boughey, Karla V Ballman, Linda M McCall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance)Bruce G Haffty, Linda M McCall, Karla V Ballman, et al.
AJR. American Journal of Roentgenology|January 31, 2018
Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)Huong T Le-Petross, Linda M McCall, Kelly K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2015
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)Judy C Boughey, Karla V Ballman, Kelly K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancerElizabeth A Mittendorf, Karla V Ballman, Linda M McCall, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JAMA|January 18, 2018
Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-ReplyKarla V Ballman, Linda M McCall, Armando E Giuliano
Journal of Biopharmaceutical Statistics|November 11, 2005
Sample size computation for two-sample noninferiority log-rank testSin-Ho Jung, Sun J Kang, Linda M McCall, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2019
Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical TrialBruce G Haffty, Linda M McCall, Karla V Ballman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancerKatherine E Posther, Linda M McCall, David H Harpole, et al.
American Journal of Surgery|September 17, 2005
Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancerA Marilyn Leitch, Peter D Beitsch, Linda M McCall, et al.
Annals of Surgery|June 29, 2017
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance)Judy C Boughey, Karla V Ballman, Linda M McCall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance)Bruce G Haffty, Linda M McCall, Karla V Ballman, et al.
AJR. American Journal of Roentgenology|January 31, 2018
Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)Huong T Le-Petross, Linda M McCall, Kelly K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2015
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)Judy C Boughey, Karla V Ballman, Kelly K Hunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancerElizabeth A Mittendorf, Karla V Ballman, Linda M McCall, et al.
Pageof 3